Characteristics | DVT group | Non-DVT group | p value |
---|---|---|---|
Age | 66.96 ± 7.57 | 68.14 ± 6.26 | 0.342 |
BMI | 24.95 ± 2.75 | 26.08 ± 3.46 | 0.091 |
High blood pressure | Â | Â | 0.878 |
 Yes | 14 (50%) | 241 (51.5%) |  |
 No | 14 (50%) | 227 (48.5%) |  |
Diabetes mellitus | Â | Â | 0.770 |
 Yes | 4 (14.3%) | 59 (12.6%) |  |
 No | 24 (85.7%) | 409 (87.4%) |  |
Coronary heart disease | Â | Â | 1 |
 Yes | 1 (3.6%) | 32 (6.8%) |  |
 No | 27 (96.4%) | 436 (93.2%) |  |
White blood cell | Â | Â | 0.108 |
 Abnormal | 3 (10.7%) | 18 (3.8%) |  |
 Normal | 25 (89.3%) | 450 (96.2%) |  |
Red blood cell | Â | Â | 0.598 |
 Abnormal | 11 (39.3%) | 161 (34.4%) |  |
 Normal | 17 (60.7%) | 307 (65.6%) |  |
Hematocrit | Â | Â | 0.182 |
 Abnormal | 14 (50%) | 175 (37.4%) |  |
 Normal | 14 (50%) | 293 (62.6%) |  |
Mean Corpuscular Volume | Â | Â | 0.335 |
 Abnormal | 2 (7.1%) | 19 (4.1%) |  |
 Normal | 26 (92.9%) | 449 (95.9%) |  |
Mean corpuscular hemoglobin | Â | Â | 0.623 |
 Abnormal | 0 (0%) | 21 (4.5%) |  |
 Normal | 28 (100%) | 447 (95.5%) |  |
Mean corpuscular hemoglobin concentration | Â | Â | 1 |
 Abnormal | 2 (7.1%) | 44 (9.4%) |  |
 Normal | 26 (92.9%) | 424 (90.6%) |  |
Red blood cell volume distribution width SD | Â | Â | 0.436 |
 Abnormal | 7 (25%) | 89 (19%) |  |
 Normal | 21 (75%) | 379 (81%) |  |
Red blood cell volume distribution width CV | Â | Â | 0.606 |
 Abnormal | 6 (21.4%) | 80 (17.1%) |  |
 Normal | 22 (78.6%) | 388 (82.9%) |  |
Platelet | Â | Â | 0.220 |
 Abnormal | 3 (10.7%) | 26 (5.6%) |  |
 Normal | 25 (89.3%) | 442 (94.4%) |  |
Platelet crit | Â | Â | 0.003 |
 Abnormal | 11 (39.3%) | 80 (17.1%) |  |
 Normal | 17 (60.7%) | 388 (82.9%) |  |
Mean Platelet Volume | Â | Â | 0.381 |
Characteristics | DVT group | Non-DVT group | p value |
 Abnormal | 5 (17.9%) | 118 (25.2%) |  |
 Normal | 23 (82.1%) | 350 (74.8%) |  |
Platelet-larger cell ratio | Â | Â | 0.634 |
 Abnormal | 8 (28.6%) | 115 (24.6%) |  |
 Normal | 20 (71.4%) | 353 (75.4%) |  |
Platelet distribution width | Â | Â | 0.014 |
 Abnormal | 8 (28.6%) | 246 (52.6%) |  |
 Normal | 20 (71.4%) | 222 (47.4%) |  |
Neutrophil | Â | Â | 0.029 |
 Abnormal | 4 (14.3%) | 18 (3.8%) |  |
 Normal | 24 (85.7%) | 450 (96.2%) |  |
Lymphocyte | Â | Â | 1 |
 Abnormal | 3 (10.7%) | 50 (10.7%) |  |
 Normal | 25 (89.3%) | 418 (89.3%) |  |
Monocyte | Â | Â | 1 |
 Abnormal | 3 (10.7%) | 56 (12%) |  |
 Normal | 25 (89.3%) | 412 (88.0%) |  |
Eosinophils | Â | Â | 0.659 |
 Abnormal | 2 (7.4%) | 25 (5.3%) |  |
 Normal | 26 (92.9%) | 443 (94.7%) |  |
Basophil | Â | Â | 0.214 |
 ≥ 0.06 | 5 (17.9%) | 49 (10.5%) |  |
 <0.06 | 23 (82.1%) | 419 (89.5%) |  |
Neutrophil% | Â | Â | 0.161 |
 Abnormal | 3 (10.7%) | 22 (4.7%) |  |
 Normal | 25 (89.3%) | 446 (95.3%) |  |
Lymphocyte% | Â | Â | 0.102 |
 Abnormal | 6 (21.4%) | 46 (9.8%) |  |
 Normal | 22 (78.6%) | 422 (90.2%) |  |
Monocyte% | Â | Â | 0.071 |
 Abnormal | 5 (17.9%) | 36 (7.7%) |  |
 Normal | 23 (82.1%) | 432 (92.3%) |  |
Eosinophils% | Â | Â | 0.709 |
 Abnormal | 2 (7.1%) | 31 (6.6%) |  |
 Normal | 26 (92.9%) | 437 (93.4%) |  |
Basophil% | Â | Â | 0.283 |
 ≥ 1 | 4 (14.3%) | 38 (8.1%) |  |
 <1 | 24 (85.7%) | 430 (91.9%) |  |
Alanine amino transferase | Â | Â | 0.054 |
 Abnormal | 5 (17.9%) | 33 (7.1%) |  |
 Normal | 23 (82.1%) | 435 (92.9%) |  |
Aspartate amino transferase | Â | Â | 0.008 |
 Abnormal | 7 (25%) | 37 (7.9%) |  |
Characteristics | DVT group | Non-DVT group | p value |
 Normal | 21 (75%) | 431 (92.1%) |  |
AST/ALT | Â | Â | 1 |
 Abnormal | 0 (0%) | 8 (1.7%) |  |
 Normal | 28 (100%) | 460 (98.3%) |  |
Total bilirubin | Â | Â | 0.619 |
 >21 | 0 (0%) | 20 (4.3%) |  |
 ≤ 21 | 28 (100%) | 448 (95.7%) |  |
Direct bilirubin | Â | Â | 0.292 |
 >4 | 2 (10.5%) | 17 (89.5%) |  |
 ≤ 4 | 26 (92.9%) | 451 (96.4%) |  |
Indirect bilirubin | Â | Â | 0.387 |
 Abnormal | 0 (0%) | 26 (5.6%) |  |
 Normal | 28 (100%) | 442 (94.4%) |  |
Total protein | Â | Â | 0.030 |
 Abnormal | 9 (32.1%) | 71 (15.2%) |  |
 Normal | 19 (67.9%) | 397 (84.8%) |  |
Serum albumin | Â | Â | 0.216 |
 Abnormal | 15 (53.6%) | 195 (41.7%) |  |
 Normal | 13 (46.4%) | 273 (58.3%) |  |
A/G | Â | Â | 0.964 |
 Abnormal | 6 (21.4%) | 102 (21.8%) |  |
 Normal | 22 (78.6%) | 366 (78.2%) |  |
Blood Urea Nitrogen | Â | Â | 1 |
 Abnormal | 4 (14.3%) | 80 (17.1%) |  |
 Normal | 24 (85.7%) | 388 (82.9%) |  |
Creatinine | Â | Â | 0.177 |
 Abnormal | 3 (10.7%) | 100 (21.4%) |  |
 Normal | 25 (89.3%) | 368 (78.6%) |  |
K | Â | Â | 1 |
 Abnormal | 3 (10.7%) | 52 (11.1%) |  |
 Normal | 25 (89.3%) | 416 (88.9%) |  |
Na | Â | Â | 1 |
 Abnormal | 2 (7.1%) | 32 (6.8%) |  |
 Normal | 26 (92.9%) | 436 (93.2%) |  |
CL | Â | Â | 0.283 |
 Abnormal | 4 (14.3%) | 38 (8.1%) |  |
 Normal | 24 (85.7%) | 430 (91.9%) |  |
Ca | Â | Â | 0.475 |
 Abnormal | 3 (10.7%) | 36 (7.7%) |  |
 Normal | 25 (89.3%) | 432 (92.3%) |  |
Procalcitonin | Â | Â | 0.000 |
 ≥ 0.51 | 12 (42.9%) | 24 (5.1%) |  |
 <0.51 | 16 (57.1%) | 444 (94.9%) |  |
Characteristics | DVT group | Non-DVT group | p value |
PT | Â | Â | 0.000 |
 Abnormal | 15 (53.6%) | 55 (11.8%) |  |
 Normal | 13 (46.4%) | 413 (88.2%) |  |
INR | Â | Â | 1 |
 Abnormal | 0 (0%) | 4 (0.9%) |  |
 Normal | 28 (100%) | 464 (99.1%) |  |
PT% | Â | Â | 1 |
 Abnormal | 1 (3.8%) | 18 (3.8%) |  |
 Normal | 27 (96.4%) | 450 (96.2%) |  |
FIB | Â | Â | 1 |
 Abnormal | 2 (7.1%) | 43 (9.2%) |  |
 Normal | 26 (92.9%) | 425 (90.8%) |  |
APTT | Â | Â | 0.007 |
 Abnormal | 4 (14.3%) | 11 (2.4%) |  |
 Normal | 24 (85.7%) | 457 (97.6%) |  |
TT | Â | Â | 1 |
 Abnormal | 0 (0%) | 11 (2.4%) |  |
 Normal | 28 (100%) | 457 (97.6%) |  |
D-Dimer | Â | Â | 0.000 |
 ≥ 0.55 | 18 (64.3%) | 121 (25.9%) |  |
 <0.55 | 10 (35.7%) | 347 (74.1%) |  |
C reactive protein | Â | Â | 0.574 |
 ≥ 5 | 5 (17.9%) | 65 (13.9%) |  |
 <5 | 23 (82.1%) | 403 (86.1%) |  |